Sequent Extended Study

NCT05788432 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2028

Last updated 2026-04-22

No results posted yet for this study

Summary

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Sequent Please Neo to meet EU Medical Device regulation (MDR) requirements in all the consecutive patients treated with Sequent Please Neo.

Conditions

Interventions

DEVICE

Sequent Please Neo

Patients in whom treatment with (Sequent Please Neo) has been attempted

Sponsors & Collaborators

  • Fundación EPIC

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-28
Primary Completion
2026-06-01
Completion
2026-07-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05788432 on ClinicalTrials.gov